共 16 条
- [1] Wu G., Wang G., Fu X., Zhu L., Synthesis, crystal structure, stacking effect and antimicrobial studies of novel quaternary copper (II) complex with quinolone, Molecules, 8, pp. 287-296, (2003)
- [2] Lg S., Wn K., Development of ciprofloxacin: the USA perspective, Ciprofloxacin: 10 years of clinical experiences, pp. 1-5, (1997)
- [3] (2009)
- [4] Blondeau J.M., Fluoroquinolones: Mechanism of action, classification, and development of resistance, Survey of Ophthalmology, 49, 2, pp. S73-S78, (2004)
- [5] Wilhelmus K.R., Hyndiuk R.A., Caldwell D.R., Abshire R.L., Folkens A.T., Godio L.B., 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The ciprofloxacin ointment/bacterial keratitis study group, Archives of Ophthalmology, 11, pp. 1210-1218, (1993)
- [6] Acar J.F., Goldstein F.W., Trends in bacterial resistance to fluoroquinolones, Clinical Infectious Diseases, 24, 1, pp. S67-S73, (1997)
- [7] Huneault L.M., Lussier B., Dubreuil P., Chouinard L., Desevaux C., Prevention and treatment of experimental osteomyelitis in dogs with ciprofloxacin-loaded crosslinked high amylose starch implants, Journal of Orthopaedic Research, 22, 6, pp. 1351-1357, (2004)
- [8] Mehnert W., Mader K., Solid lipid nanoparticles: production, characterization and applications, Advanced Drug Delivery Reviews, 47, 2-3, pp. 165-196, (2001)
- [9] McCarron P.A., Hall M., International Journal of Pharmaceutics, 348, pp. 115-124, (2008)
- [10] Goya S., Rai J.K., Narang R.K., Rajesh K.S., International Journal of Pharmacy and Pharmaceutical Sciences, 2, 2, pp. 1-6, (2010)